122 related articles for article (PubMed ID: 17953445)
21. Pulmonary administration of PEGylated polylysine dendrimers: absorption from the lung versus retention within the lung is highly size-dependent.
Ryan GM; Kaminskas LM; Kelly BD; Owen DJ; McIntosh MP; Porter CJ
Mol Pharm; 2013 Aug; 10(8):2986-95. PubMed ID: 23750747
[TBL] [Abstract][Full Text] [Related]
22. Dendrimers as versatile platform in drug delivery applications.
Svenson S
Eur J Pharm Biopharm; 2009 Mar; 71(3):445-62. PubMed ID: 18976707
[TBL] [Abstract][Full Text] [Related]
23. Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.
Kaminskas LM; Boyd BJ; Porter CJ
Nanomedicine (Lond); 2011 Aug; 6(6):1063-84. PubMed ID: 21955077
[TBL] [Abstract][Full Text] [Related]
24. Modifications in the chemical structure of Trojan carriers: impact on cargo delivery.
Aussedat B; Dupont E; Sagan S; Joliot A; Lavielle S; Chassaing G; Burlina F
Chem Commun (Camb); 2008 Mar; (12):1398-400. PubMed ID: 18338035
[TBL] [Abstract][Full Text] [Related]
25. [Lysine dendrimers as vectors for delivering genetic constructs to eukaryotic cells].
Kiselev AV; Il'ina PL; Egorova AA; Baranov AN; Gur'ianov IA; Baianova NV; Tarasenko II; Lesina EA; Vlasov GP; Baranov VS
Genetika; 2007 Jun; 43(6):725-33. PubMed ID: 17853798
[TBL] [Abstract][Full Text] [Related]
26. Structural advantage of dendritic poly(L-lysine) for gene delivery into cells.
Yamagata M; Kawano T; Shiba K; Mori T; Katayama Y; Niidome T
Bioorg Med Chem; 2007 Jan; 15(1):526-32. PubMed ID: 17035030
[TBL] [Abstract][Full Text] [Related]
27. Efficient delivery of siRNA using dendritic poly(L-lysine) for loss-of-function analysis.
Inoue Y; Kurihara R; Tsuchida A; Hasegawa M; Nagashima T; Mori T; Niidome T; Katayama Y; Okitsu O
J Control Release; 2008 Feb; 126(1):59-66. PubMed ID: 18055057
[TBL] [Abstract][Full Text] [Related]
28. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer.
Shan X; Liu C; Yuan Y; Xu F; Tao X; Sheng Y; Zhou H
Colloids Surf B Biointerfaces; 2009 Sep; 72(2):303-11. PubMed ID: 19450955
[TBL] [Abstract][Full Text] [Related]
29. Host-guest chemistry of dendrimer-drug complexes. 2. Effects of molecular properties of guests and surface functionalities of dendrimers.
Hu J; Cheng Y; Wu Q; Zhao L; Xu T
J Phys Chem B; 2009 Aug; 113(31):10650-9. PubMed ID: 19603764
[TBL] [Abstract][Full Text] [Related]
30. Proteolysis of peptide dendrimers.
Sommer P; Fluxa VS; Darbre T; Reymond JL
Chembiochem; 2009 Jun; 10(9):1527-36. PubMed ID: 19434653
[TBL] [Abstract][Full Text] [Related]
31. Unexpected in vivo anti-inflammatory activity observed for simple, surface functionalized poly(amidoamine) dendrimers.
Chauhan AS; Diwan PV; Jain NK; Tomalia DA
Biomacromolecules; 2009 May; 10(5):1195-202. PubMed ID: 19348417
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics and metabolism of intravenous pirfenidone in sheep.
Bruss ML; Stanley SD; Margolin SB; Giri SN
Biopharm Drug Dispos; 2008 Mar; 29(2):119-26. PubMed ID: 18176939
[TBL] [Abstract][Full Text] [Related]
33. Potential of poly(amidoamine) dendrimers as drug carriers of camptothecin based on encapsulation studies.
Cheng Y; Li M; Xu T
Eur J Med Chem; 2008 Aug; 43(8):1791-5. PubMed ID: 18215444
[TBL] [Abstract][Full Text] [Related]
34. The effect of surface functionality on cellular trafficking of dendrimers.
Perumal OP; Inapagolla R; Kannan S; Kannan RM
Biomaterials; 2008; 29(24-25):3469-76. PubMed ID: 18501424
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of recombinant human soluble thrombomodulin, thrombomodulin alfa in the rat.
Tsuruta K; Kodama T; Serada M; Hori K; Inaba A; Miyake T; Kohira T
Xenobiotica; 2009 Feb; 39(2):125-34. PubMed ID: 19255938
[TBL] [Abstract][Full Text] [Related]
36. The absorption, distribution, metabolism and elimination of bevirimat in rats.
Bullock P; Larsen D; Press R; Wehrman T; Martin DE
Biopharm Drug Dispos; 2008 Oct; 29(7):396-405. PubMed ID: 18615840
[TBL] [Abstract][Full Text] [Related]
37. Fluorescent dendrimers with a peptide cathepsin B cleavage site for drug delivery applications.
Fuchs S; Otto H; Jehle S; Henklein P; Schluter AD
Chem Commun (Camb); 2005 Apr; (14):1830-2. PubMed ID: 15795757
[TBL] [Abstract][Full Text] [Related]
38. Kinetics and effects of dichloroacetic acid in rainbow trout.
Fitzsimmons PN; Hoffman AD; Lien GJ; Hammermeister DE; Nichols JW
Aquat Toxicol; 2009 Sep; 94(3):186-94. PubMed ID: 19656582
[TBL] [Abstract][Full Text] [Related]
39. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy.
Perucca E; Cloyd J; Critchley D; Fuseau E
Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564
[TBL] [Abstract][Full Text] [Related]
40. Improving the signal-to-noise performance of molecular diagnostics with PEG-lysine copolymer dendrons.
Kozak D; Surawski P; Thoren KM; Lu CY; Marcon L; Trau M
Biomacromolecules; 2009 Feb; 10(2):360-5. PubMed ID: 19159279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
